LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 22

Search options

  1. Article ; Online: Increase in False-Positive Fourth-Generation Human Immunodeficiency Virus Tests in Patients With Coronavirus Disease 2019.

    Gudipati, Smitha / Shallal, Anita / Peterson, Edward / Cook, Bernard / Markowitz, Norman

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2023  Volume 77, Issue 4, Page(s) 615–619

    Abstract: Background: We observed an increase in the frequency of false-positive (FP) human immunodeficiency virus (HIV) test results that correlated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) prevalence. We measured FP rates of laboratory- ... ...

    Abstract Background: We observed an increase in the frequency of false-positive (FP) human immunodeficiency virus (HIV) test results that correlated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) prevalence. We measured FP rates of laboratory-based fourth-generation HIV antigen/antibody test among those with polymerase chain reaction (PCR)-confirmed infection with SARS-CoV-2 compared with FP rate of those who tested SARS-CoV-2 PCR-negative.
    Methods: All patients PCR tested for SARS-CoV-2 within 2 weeks of an HIV fourth-generation assay were selected. Positive HIV fourth-generation assays were reviewed and divided into groups of FP, true positive (TP), and presumptive negative (PN). Variables included age, race, ethnicity, gender, pregnancy, and Coronavirus Disease 2019 (COVID-19) immunization status. Associations with positive SARS-CoV-2 tests were assessed using linear logistic regression. Multivariate logistic regression was used to assess sets of variables.
    Results: There were 31 910 medical records that met criteria. The frequency of SARS-CoV-2 positive tests was calculated in groups of HIV TP, FP, and PN. In total, 31 575 patients had PN HIV test result, 248 patients had TP, and 87 patients had FP. Those with HIV FP tests had the highest percentage of COVID-19-positive test results at 19.5%, which was significantly higher than HIV PN (11.3%; P = .016) and HIV TP (7.7%; P = .002). After adjustment for all covariates, only FP HIV was significantly associated with COVID-19 (odds ratio, 4.22; P = .001).
    Conclusions: This study reveals that patients with positive SARS-CoV-2 PCR tests are significantly more likely to have an FP fourth-generation HIV test than those with negative SARS-CoV-2 PCR tests.
    MeSH term(s) Pregnancy ; Female ; Humans ; COVID-19/diagnosis ; SARS-CoV-2 ; Sensitivity and Specificity ; HIV Seropositivity ; HIV
    Language English
    Publishing date 2023-05-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciad264
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Expect the Unexpected: A Rare Case of

    Ramireddy, Swetha / Gudipati, Smitha / Zervos, Marcus

    IDCases

    2020  Volume 21, Page(s) e00787

    Abstract: Infective endocarditis (IE) caused ... ...

    Abstract Infective endocarditis (IE) caused by
    Keywords covid19
    Language English
    Publishing date 2020-05-12
    Publishing country Netherlands
    Document type Case Reports
    ZDB-ID 2745454-X
    ISSN 2214-2509
    ISSN 2214-2509
    DOI 10.1016/j.idcr.2020.e00787
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus.

    Fernandez, Omar E / Gudipati, Smitha / Ko, Dayoung / Boucher, Alison / Brar, Indira

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2022  Volume 75, Issue 1, Page(s) 172–175

    MeSH term(s) HIV ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Papillomaviridae ; Papillomavirus Infections/complications
    Language English
    Publishing date 2022-08-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciab853
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Can the One Health Approach Save Us from the Emergence and Reemergence of Infectious Pathogens in the Era of Climate Change: Implications for Antimicrobial Resistance?

    Gudipati, Smitha / Zervos, Marcus / Herc, Erica

    Antibiotics (Basel, Switzerland)

    2020  Volume 9, Issue 9

    Abstract: Climate change has become a controversial topic in today's media despite decades of warnings from climate scientists and has influenced human health significantly with the increasing prevalence of infectious pathogens and contribution to antimicrobial ... ...

    Abstract Climate change has become a controversial topic in today's media despite decades of warnings from climate scientists and has influenced human health significantly with the increasing prevalence of infectious pathogens and contribution to antimicrobial resistance. Elevated temperatures lead to rising sea and carbon dioxide levels, changing environments and interactions between humans and other species. These changes have led to the emergence and reemergence of infectious pathogens that have already developed significant antimicrobial resistance. Although these new infectious pathogens are alarming, we can still reduce the burden of infectious diseases in the era of climate change if we focus on One Health strategies. This approach aims at the simultaneous protection of humans, animals and environment from climate change and antimicrobial impacts. Once these relationships are better understood, these models can be created, but the support of our legislative and health system partnerships are critical to helping with strengthening education and awareness.
    Keywords covid19
    Language English
    Publishing date 2020-09-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2681345-2
    ISSN 2079-6382
    ISSN 2079-6382
    DOI 10.3390/antibiotics9090599
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Atypical presentation of progressive disseminated histoplasmosis in a patient recently diagnosed with AIDS.

    Stefan, Andrew J / Herc, Erica S / Gudipati, Smitha / Brar, Indira / Vitale, Alyssa / Tariq, Zain

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2022  Volume 127, Page(s) 45–47

    Abstract: Opportunistic infections, including progressive disseminated histoplasmosis (PDH), may have variable and surprising presentations in patients with AIDS. This can be either a primary infection or reactivation of a latent infection. Latent infections may ... ...

    Abstract Opportunistic infections, including progressive disseminated histoplasmosis (PDH), may have variable and surprising presentations in patients with AIDS. This can be either a primary infection or reactivation of a latent infection. Latent infections may occur due to being unmasked by the immune reconstitution inflammatory syndrome after the initiation of combined antiretroviral therapy. PDH can be difficult to diagnose in patients with AIDS due to its variable presentation and many overlapping symptoms with other opportunistic infections. Serum and urine antigen testing are highly sensitive and typically used as the initial diagnostic test to workup suspected PDH. However, negative antigen and antibody tests do not rule out Histoplasmosis capsulatum infection and suspicion should remain high for PDH in the right clinical context. A definitive diagnosis may require biopsy-proven narrow-based budding yeast. We present an interesting patient with AIDS who presented with worsening cognitive decline and was ultimately diagnosed with PDH based on biopsy histopathology in the setting of negative antigen and antibody testing.
    MeSH term(s) Humans ; Histoplasmosis/diagnosis ; Histoplasmosis/drug therapy ; Acquired Immunodeficiency Syndrome/complications ; HIV Infections/complications ; Opportunistic Infections ; Antigens, Fungal ; Histoplasma
    Chemical Substances Antigens, Fungal
    Language English
    Publishing date 2022-12-01
    Publishing country Canada
    Document type Case Reports
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2022.11.036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Occurrence of the S230R integrase strand inhibitor mutation in a treatment-naïve individual case report.

    Gudipati, Smitha / Brar, Indira / Golembieski, Alicia / Hanna, Zachary / Markowitz, Norman

    Medicine

    2020  Volume 99, Issue 27, Page(s) e20915

    Abstract: Rationale: Transmitted resistance to integrase strand inhibitors (INSTI) has been uncommon, but is slowly becoming more prevalent among those living with HIV. In an era with 2-drug regimens for antiretroviral therapy, transmitted resistance for INSTI is ...

    Abstract Rationale: Transmitted resistance to integrase strand inhibitors (INSTI) has been uncommon, but is slowly becoming more prevalent among those living with HIV. In an era with 2-drug regimens for antiretroviral therapy, transmitted resistance for INSTI is alarming.
    Patient concerns: A 28-year-old African American female was recently diagnosed with HIV during a 30-week prenatal visit.
    Diagnosis: HIV 4th generation test was positive as well as confirmation. Genotype was performed using next generation sequencing.
    Interventions: Patient was initially rapidly started on a dolutegravir based regimen and changed to a protease inhibitor regimen once her genotype reported an S230R mutation.
    Outcomes: Patient became virally suppressed on antiretroviral therapy and delivered an HIV negative baby.
    Lessons: INSTI resistance testing should be done for treatment-naïve and INSTI-naïve persons, particularly when considering 2 drug INSTI based regimens.
    MeSH term(s) Adult ; Drug Resistance, Viral ; Female ; Genotype ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV Integrase Inhibitors/adverse effects ; HIV-1/genetics ; Humans ; Mutation ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/virology ; Prenatal Diagnosis ; Protease Inhibitors/administration & dosage ; Protease Inhibitors/therapeutic use
    Chemical Substances HIV Integrase Inhibitors ; Protease Inhibitors
    Keywords covid19
    Language English
    Publishing date 2020-07-06
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80184-7
    ISSN 1536-5964 ; 0025-7974
    ISSN (online) 1536-5964
    ISSN 0025-7974
    DOI 10.1097/MD.0000000000020915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit.

    Gudipati, Smitha / Lee, Monica / Scott, Megan / Yaphe, Sean / Huisting, Joanne / Yared, Nicholas / Brar, Indira / Markowitz, Norman

    International journal of STD & AIDS

    2022  Volume 33, Issue 6, Page(s) 554–558

    Abstract: Background: COVID-19, a novel respiratory illness caused by SARS-CoV-2, has become a global pandemic. As of December 2020, 4.8% of the 941 people living with HIV in our Ryan White clinic have tested polymerase chain reaction positive for SARS-CoV-2. The ...

    Abstract Background: COVID-19, a novel respiratory illness caused by SARS-CoV-2, has become a global pandemic. As of December 2020, 4.8% of the 941 people living with HIV in our Ryan White clinic have tested polymerase chain reaction positive for SARS-CoV-2. The aim of our study was to estimate the seroprevalence of COVID-19 in our Ryan White people living with HIV, irrespective of known past infection.
    Methods: We conducted a cross-sectional study that recruited people living with HIV in the Ryan White program at Henry Ford Hospital in Detroit, Michigan, from September 2020 through May 2021. All Ryan White patients were offered participation during clinic visits. After informed consent, patients completed a survey, and had blood sampled for SARS-CoV-2 antibody testing.
    Results: Of the 529 individuals who completed the written survey, 504 participants were tested for SARS-CoV-2 antibody and 52 people living with HIV were COVID-19 immunoglobulin (Ig) G positive resulting in a seroprevalence of 10.3%. Among 36 persons with PCR-confirmed COVID-19, 52.8% were IgG negative. Inclusion of PCR positive but IgG-negative people living with HIV yields a COVID-19 infection prevalence of 14.1%.
    Conclusions: These findings suggest that passive public health-based antibody surveillance in people living with HIV significantly underestimates past infection.
    MeSH term(s) Antibodies, Viral ; COVID-19/epidemiology ; Cross-Sectional Studies ; HIV Infections/epidemiology ; Humans ; Immunoglobulin G ; SARS-CoV-2 ; Seroepidemiologic Studies
    Chemical Substances Antibodies, Viral ; Immunoglobulin G
    Language English
    Publishing date 2022-03-25
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 1018089-8
    ISSN 1758-1052 ; 0956-4624
    ISSN (online) 1758-1052
    ISSN 0956-4624
    DOI 10.1177/09564624221076629
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Descriptive Analysis of Patients Living With HIV Affected by COVID-19.

    Gudipati, Smitha / Brar, Indira / Murray, Shannon / McKinnon, John E / Yared, Nicholas / Markowitz, Norman

    Journal of acquired immune deficiency syndromes (1999)

    2020  Volume 85, Issue 2, Page(s) 123–126

    Abstract: Background: COVID-19 disease has spread globally and was declared a pandemic on March 11, 2020, by the World Health Organization. On March 10, the State of Michigan confirmed its first 2 cases of COVID-19, and the number of confirmed cases has reached ... ...

    Abstract Background: COVID-19 disease has spread globally and was declared a pandemic on March 11, 2020, by the World Health Organization. On March 10, the State of Michigan confirmed its first 2 cases of COVID-19, and the number of confirmed cases has reached 47,182 as of May 11, 2020, with 4555 deaths.
    Setting: Currently, little is known if patients living with HIV (PLWH) are at a higher risk of severe COVID-19 or if their antiretrovirals are protective. This study presents epidemiologic and clinical features of COVID-19 infected PLWH in Detroit, Michigan.
    Methods: This is a case series that included 14 PLWH with laboratory-confirmed COVID-19 infection who were evaluated at Henry Ford Hospital in Detroit, Michigan, between March 20, 2020, and April 30, 2020.
    Results: Fourteen PLWH were diagnosed with COVID-19. Twelve patients were men and 2 were women; 13 patients were virally suppressed. Eight patients were hospitalized, and 6 patients were told to self-quarantine at home after their diagnoses. Three patients who were admitted expired during their hospital stay. No patient required bilevel positive airway pressure or nebulizer use in the emergency department, and none developed acute respiratory distress syndrome, pulmonary embolism, deep venous thrombosis, or a cytokine storm while on therapy for COVID-19.
    Conclusion: Although the clinical spectrum of COVID-19 among PLWH cannot be fully ascertained by this report, it adds to the data that suggest that HIV-positive patients with SARS-CoV-2 infection are not at a greater risk of severe disease or death as compared to HIV-negative patients.
    MeSH term(s) African Americans ; COVID-19 ; Comorbidity ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/ethnology ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; HIV Infections/ethnology ; Hispanic Americans ; Humans ; Male ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/ethnology
    Keywords covid19
    Language English
    Publishing date 2020-07-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/QAI.0000000000002450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Occurrence of the S230R integrase strand inhibitor mutation in a treatment-naïve individual case report

    Gudipati, Smitha / Brar, Indira / Golembieski, Alicia / Hanna, Zachary / Markowitz, Norman

    Medicine (Baltimore)

    Abstract: RATIONALE: Transmitted resistance to integrase strand inhibitors (INSTI) has been uncommon, but is slowly becoming more prevalent among those living with HIV. In an era with 2-drug regimens for antiretroviral therapy, transmitted resistance for INSTI is ... ...

    Abstract RATIONALE: Transmitted resistance to integrase strand inhibitors (INSTI) has been uncommon, but is slowly becoming more prevalent among those living with HIV. In an era with 2-drug regimens for antiretroviral therapy, transmitted resistance for INSTI is alarming. PATIENT CONCERNS: A 28-year-old African American female was recently diagnosed with HIV during a 30-week prenatal visit. DIAGNOSIS: HIV 4th generation test was positive as well as confirmation. Genotype was performed using next generation sequencing. INTERVENTIONS: Patient was initially rapidly started on a dolutegravir based regimen and changed to a protease inhibitor regimen once her genotype reported an S230R mutation. OUTCOMES: Patient became virally suppressed on antiretroviral therapy and delivered an HIV negative baby. LESSONS: INSTI resistance testing should be done for treatment-naïve and INSTI-naïve persons, particularly when considering 2 drug INSTI based regimens.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32629687
    Database COVID19

    Kategorien

  10. Article ; Online: Descriptive Analysis of Patients Living with HIV Affected By COVID-19

    Gudipati, Smitha / Brar, Indira / Murray, Shannon / McKinnon, John E. / Yared, Nicholas / Markowitz, Norman

    JAIDS Journal of Acquired Immune Deficiency Syndromes

    2020  Volume Publish Ahead of Print

    Keywords Pharmacology (medical) ; Infectious Diseases ; covid19
    Language English
    Publisher Ovid Technologies (Wolters Kluwer Health)
    Publishing country us
    Document type Article ; Online
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/qai.0000000000002450
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top